ReviewBorderline personality disorder and emotion dysregulation2018
Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients.
Review in Borderline personality disorder and emotion dysregulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.Molecular psychiatry · 2019Trial
- White matter signatures of addiction diverge across opioids, cannabis and nicotine and predict impulsive choice in cannabis dependence.Translational psychiatry · 2026Article
- Non-death losses experienced by Black adults who use opioids.Journal of loss & trauma · 2026Article
- A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder.Journal of substance use and addiction treatment · 2025Observational
- Maternal psychophysiology profiles: associations with prenatal opioid use, maternal emotion dysregulation, and newborn neurobehavior.Pediatric research · 2025Article
- Indirect effects of emotion regulation in the relationship between pain and cannabis use in adults 18-64 years.Addictive behaviors · 2024Article
- Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.British journal of haematology · 2024Article
- Addictive and other mental disorders: a call for a standardized definition of dual disorders.Translational psychiatry · 2022Review
- The who and what of validation: an experimental examination of validation and invalidation of specific emotions and the moderating effect of emotion dysregulation.Borderline personality disorder and emotion dysregulation · 2022Article
- Dialectical Pain Management: Feasibility of a Hybrid Third-Wave Cognitive Behavioral Therapy Approach for Adults Receiving Opioids for Chronic Pain.Pain medicine (Malden, Mass.) · 2021Article
- Role of affective instability on suicidal risk in complex regional pain syndrome: a diary approach (preliminary report).The Korean journal of pain · 2021Article
- Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain?Psychology, health & medicine · 2020Article
- Pain Experiences and Their Relation to Opioid Misuse Risk and Emotion Dysregulation.Pain research & management · 2020Article
- Experiential Avoidance, Pain, and Suicide Risk in a National Sample of Gulf War Veterans.Archives of suicide research : official journal of the International Academy for Suicide ResearchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundChronic pain is a prevalent condition that causes functional impairment and emotional suffering. To allay pain-induced suffering, opioids are often prescribed for chronic pain management. Yet, chronic pain patients on opioid therapy are at heightened risk for opioid misuse-behaviors that can lead to addiction and overdose. Relatedly, chronic pain patients are at elevated risk for suicidal ideation and suicidal behaviors. MAIN BODY: Opioid misuse and suicidality are maladaptive processes aimed at alleviating the negative emotional hyperreactivity, hedonic hyporeactivity, and emotion dysregulation experienced by chronic pain patients on opioid therapy. In this review, we explore the role of emotion dysregulation in chronic pain. We then describe why emotionally dysregulated chronic pain patients are vulnerable to opioid misuse and suicidality in response to these negative affective states.
conclusionEmotion dysregulation is an important and malleable treatment target with the potential to reduce or prevent opioid misuse and suicidality among opioid-treated chronic pain patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.